Organizer
Waters Corporation
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
GPC/SEC
LinkedIn Logo

Leveraging SEC-MALS for Regulatory-Aligned Biosimilarity Assessment

RECORD | Already taken place Th, 26.2.2026
Learn how SEC-MALS supports confident biosimilar comparability by accurately characterizing molecular weight, aggregation, and key CQAs in line with FDA and ICH Q6B guidance.
Go to the webinar
Waters Corporation: Leveraging SEC-MALS for Regulatory-Aligned Biosimilarity Assessment
Waters Corporation: Leveraging SEC-MALS for Regulatory-Aligned Biosimilarity Assessment

Unlock the Secrets of Biosimilarity: Master SEC-MALS for Confident Comparability

Assessing biosimilarity requires a robust suite of analytical tools that directly address the biophysical characterization parameters emphasized in the latest US FDA biosimilar guidance and ICH Q6B.

Size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) has emerged as a critical technique for defining molecular weight, aggregation, impurity profiles, and related quality attributes that underpin regulatory decision-making. 
In this webinar, we will discuss how SEC-MALS can be applied to key biosimilar comparability challenges, including quantifying molecular weight, aggregates and reversible aggregates, confirming identity, and measuring extinction coefficients.

Why should you attend?

  • Get clarity on key biophysical characterization parameters outlined in ICH Q6B. 
  • Understand how SEC-MALS addresses critical quality attributes (CQAs) for biosimilars and other biologic modalities. 
  • Build confidence in light scattering fundamentals and their role in macromolecule characterization. 

Who should attend?

  • This webinar is designed for you if you work on antibody or protein therapeutic characterization in discovery, development, quality control, or analytical services.

Don’t miss this opportunity to strengthen your expertise and stay ahead in biosimilar development.

Register now and secure your spot!

Presenter: Bretton Fletcher, Ph.D. (Scientist, Waters | Wyatt Technology)

Bretton Fletcher is an application scientist in the Analytical Sciences team at Waters | Wyatt Technology. He assists customers in identifying the best light scattering solutions for their analytical needs by leveraging her expertise in multi-angle light scattering. He performs feasibility studies to characterize customer samples and participates in Wyatt’s Light Scattering University. He completed his Ph.D. in Biomolecular Sciences and Engineering from the University of California, Santa Barbara.

Waters Corporation
LinkedIn Logo
 

Related content

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike